• Business
  • Entertainment
  • Health
  • News
  • Sport
  • Tech
  • World
Newsy Today
news of today
Home - farmacias
Tag:

farmacias

Health

Argentina: Drug Shortages Loom Due to Payment Delays

by Chief Editor February 21, 2026
written by Chief Editor

Argentina Faces Potential Medicine Shortages as Payment Delays Mount

Argentina’s pharmaceutical sector is sounding the alarm over potential medicine shortages across the country. The core issue? Significant delays in payments from health insurance providers and prepaid medicine companies to pharmacies. This financial strain threatens the consistent supply of essential medications, impacting patients who rely on ongoing treatments.

The Financial Strain on Pharmacies

The Argentine Pharmaceutical Confederation (COFA) reports that many pharmacies are still awaiting payments for services rendered in December 2025. Despite this, they are obligated to cover operational costs and supplier payments using their own funds. This creates a substantial financial gap, forcing pharmacies to essentially finance medications after they’ve already been dispensed.

Alejandra Gómez, president of COFA, warns that dwindling stock levels are a real possibility if the situation doesn’t improve quickly. Pharmacies operate on tight weekly payment schedules with drugstores and laboratories, creating constant financial pressure and hindering the replenishment of products.

PAMI: A Critical Point of Concern

The National Institute of Social Security for Retirees and Pensioners (PAMI) is a major focal point of concern due to its large membership and high demand for medications. Delays in PAMI payments force pharmacies to cover the cost of prescriptions filled for retirees and pensioners with their own capital – a situation the sector deems unsustainable in the long term.

Widespread Delays Across the Healthcare System

The problem extends beyond PAMI. Pharmacies in various provinces are also reporting delays related to provincial health insurance and some prepaid plans. This widespread issue is creating tension throughout the entire healthcare supply chain.

Seeking a Collaborative Solution

COFA is advocating for the formation of a dialogue table involving pharmacies, laboratories, health insurance providers, and prepaid companies. The goal is to find an urgent solution to prevent a financial crisis from escalating into a broader healthcare problem affecting millions of Argentinian patients.

What Does This Mean for Patients?

Prolonged payment delays could lead to a domino effect, complicating access to essential treatments, particularly for individuals with chronic illnesses. The potential for medicine shortages raises serious concerns about the continuity of care for vulnerable populations.

Pro Tip:

If you are concerned about accessing your medications, proactively communicate with your pharmacy and healthcare provider. Discuss potential alternatives or strategies to ensure uninterrupted treatment.

FAQ

Q: What is causing the payment delays?
A: Delays are occurring with payments from health insurance providers and prepaid medicine companies to pharmacies.

Q: Which organization is most affected?
A: PAMI, due to its large number of affiliates and high medication demand, is a significant concern.

Q: What is COFA doing to address the issue?
A: COFA is pushing for a collaborative dialogue between all stakeholders to find a swift resolution.

Q: Could this lead to medicine shortages?
A: Yes, if the payment delays continue, pharmacies may struggle to replenish their stock, potentially leading to shortages.

Q: What can patients do?
A: Patients should communicate with their pharmacy and healthcare provider to discuss potential solutions.

Did you understand? The financial health of pharmacies is directly linked to the accessibility of medications for all Argentinians.

Stay informed about developments in the Argentinian healthcare system. Explore our other articles on healthcare access and pharmaceutical industry trends.

Have questions or concerns? Share your thoughts in the comments below!

February 21, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Understanding the High Failure Rate: Analyzing Why 1 in 10 People Struggle to Succeed

by Chief Editor May 5, 2025
written by Chief Editor

The Future of Artificial Intelligence in Healthcare: Navigating New Horizons

The dawn of AI-prescribers might not be as far off as we think. As lawmakers like David Schweikert propose new legislation paving the way for AI to directly prescribe medications, the healthcare landscape is teetering on the brink of transformation. But what does this mean for the future of healthcare?

Understanding AI-Prescription Proposals

The bill that once seemed speculative, as highlighted by El Español, introduces AI in healthcare deal with a massive financial challenge—the staggering 18% healthcare expenditure in the US. With AI, the opportunity arises to streamline patient management and reduce costs by making medical prescriptions more efficient and precise.

Experts like Javier García Alegría, former president of the Federation of Scientific Medical Associations in Spain, highlight the existing conditions that make such proposals look appealing—a significant healthcare spending gap, inadequate scientific acknowledgment, regulatory rollbacks, and powerful tech lobbying. However, they also underline the complexity and risks involved.

Despite AI’s burgeoning role in diagnosis and treatment planning, the consensus is the need for critical appraisal and careful implementation. AI’s role in medicine isn’t just about data; it encapsulates understanding intricate clinical situations and patient preferences, which are uniquely human.

Current AI Integration in Medicine

AI isn’t new to healthcare; its application spans diverse fields like genomics, risk stratification, clinical documentation, and more, as explained by physician and internist Javier García Alegría. Recent surveys reveal that roughly 75% of European doctors have engaged with AI tools, mainly for research and administrative tasks.

Yet, as César Dilú from SEMG points out, primary care lags behind in AI adoption. Although AI’s precision is impressive—with 90% accuracy—the shortcomings show up in daily medical practice, with errors becoming a concern if unchecked by a medical professional.

Anticipating AI’s Potential and Limitations

The journey of AI in prescribing may fruition in the next few years, according to Dilú. While tool accuracy is improving, real-time decision-making in dynamic clinical environments still necessitates human oversight. This collaboration promises improved prescription accuracy, reduced overuse of medications like antibiotics, and minimized drug interactions, as illustrated by studies from Singapur.

Ramón Puchades from SEMI emphasizes the potential of AI to personalize treatment. His vision integrates clinical and genetic data, potentially revolutionizing personalized medicine. Yet, AI should not eclipse the nuanced judgement of healthcare providers who play pivotal roles in decision-making and prioritizing patient welfare.

The Role of Regulatory Frameworks

In Europe and Spain, however, existing legislative hurdles concerning data access pose challenges to AI integration, contrasting sharply with the American system. Previous strides like the LOLA assistant app at Hospital de Bellvitge have demonstrated high user acceptance, offering a glimpse into the potential benefits of AI systems in healthcare.

Looking Forward: AI and the Future of Healthcare

As we tread cautiously on this path, several questions and considerations arise: How soon will AI begin handling simple prescription renewals? Will regulatory frameworks evolve to support AI’s growth while safeguarding patient interests? And how might AI reshape the dynamic between healthcare provider and patient?

Frequently Asked Questions (FAQ)

What is AI currently doing in medicine? AI is utilized in diagnostics, risk assessment, and administrative tasks, but not yet independently prescribing.

How accurate is AI in medicine today? Advanced AI models boast around 90% accuracy but with room for improvement.

Is AI ready to replace doctors in prescribing? No, AI is intended to augment, not replace, the nuanced judgments of medical professionals.

Did You Know?

An AI system reduced antibiotic prescriptions by 40% in specific cases at Singapur’s Hospital General by identifying unnecessary treatments.

Pro Tips

Explore case studies and research articles to stay informed about how AI is shaping healthcare. Recognize its potential to drive innovations that can enhance patient care, but prioritize ethical considerations and a balanced blend of human oversight and AI efficiency.

Engage in the dialogue about AI in healthcare. It’s a platform where your voice can help shape future policies and practices, ensuring that technology enhances, rather than overshadows, personalized care.

Subscribe to our newsletter for the latest updates in AI and healthcare innovation. Let’s delve deeper into this fascinating intersection of technology and medicine.

May 5, 2025 0 comments
0 FacebookTwitterPinterestEmail
Health

Colegio de Farmacéuticos urge al Gobierno replantear decreto que afecta la industria y encareció algunos medicamentos

by Chief Editor April 2, 2025
written by Chief Editor

Costa Rica’s Pharmaceutical Regulation: A Model of Unintended Consequences?

Costa Rica’s recent executive decree, intended to cap profit margins in the pharmaceutical industry, has sparked significant debate. Expected to lower medication prices, the decree instead saw prices rise for certain drugs. This unexpected outcome has broader implications for regulatory practices in the healthcare sector.

Unintended Consequences and Market Dynamics

Following the decree, businesses have reacted by closing operations, highlighting the complexities of price regulation. The exit of at least two distributors underscores how tightly interconnected local distribution networks are. Reports claim that this move has reduced market competition, affecting drug availability, especially outside urban areas.

“What happens in Costa Rica could serve as a valuable lesson for other countries considering similar measures,” suggests a leading academic in healthcare economics. The loss of distribution channels raises critical questions about balancing regulation with market freedom.

Need for Stakeholder Collaboration

A consensus is growing among stakeholders that previous initiatives lacked inclusive dialogue. Officials, including government representatives and industry experts, advocate for a collaborative platform to reassess strategies impacting medicinal prices. The need for an inclusive approach is emphasized by stakeholders such as José Gatgens, president of the Costa Rican Pharmacists’ College.

Market Impact and Consumer Affected

Real-world cases show mixed results. Some medications have become cheaper, while others have increased in price due to supply chain adjustments. For instance, the Avamy nasal spray saw a significant price hike, a direct consequence of distributor withdrawal, impacting availability for end consumers. Similarly, the Urea cream experienced price inflation, affecting personal budgets.

Has the Impact Been Fully Assessed?

Governing bodies have yet to provide a comprehensive assessment of the decree’s effects. This gap highlights a need for evidence-based diagnostics before implementing broad regulatory changes. Governments could benefit from open access to real-time market data to make informed decisions.

FAQs About Pharmaceutical Regulation

Q: What is the main criticism of the decree?

A: The decree was criticized for lacking input from key stakeholders, leading to supply chain disruptions and market volatility.

Q: Could these measures affect drug availability?

A: Yes, distributor exits have already impacted the availability of some medications, especially in remote areas.

Q: Is there a plan to reconsider the decree?

A: Discussions are ongoing to potentially revise the decree and introduce a more balanced regulatory framework.

Looking Forward: Regulatory Evolution?

Looking ahead, there’s potential for new models in pharmaceutical regulation internationally. Experts suggest that lessons from Costa Rica could inform policies that ensure fair pricing without compromising market dynamics. Collaboration between governments, industry players, and consumers is crucial for sustainable regulatory frameworks that protect public interests while encouraging market participation.

Pro Tip: Engage with local healthcare bodies to understand regional impacts privately and incorporate community feedback into policy reforms.

Conclusion: A Call to Engage

What are your thoughts on this regulatory approach? Join the discussion by leaving a comment below, or explore more on this topic by subscribing to our newsletter.

April 2, 2025 0 comments
0 FacebookTwitterPinterestEmail

Recent Posts

  • Oil Prices Surge Amid US-Iran Tensions and Hormuz Strait Closure

    April 21, 2026
  • Fuel supply not at risk due to good terms with Iran, Mantashe says

    April 21, 2026
  • Oil Prices Surge Amid US-Iran Tensions and Hormuz Strait Closure

    April 21, 2026
  • Steeds Meer Mannen Kiezen Voor Cosmetische Ingrepen

    April 21, 2026
  • Norwegian Athletics Stars Outraged by Sports Director Erlend Slokvik’s Forced Exit

    April 21, 2026

Popular Posts

  • 1

    Maya Jama flaunts her taut midriff in a white crop top and denim jeans during holiday as she shares New York pub crawl story

    April 5, 2025
  • 2

    Saar-Unternehmen hoffen auf tiefgreifende Reformen

    March 26, 2025
  • 3

    Marta Daddato: vita e racconti tra YouTube e podcast

    April 7, 2025
  • 4

    Unlocking Success: Why the FPÖ Could Outperform Projections and Transform Austria’s Political Landscape

    April 26, 2025
  • 5

    Mecimapro Apologizes for DAY6 Concert Chaos: Understanding the Controversy

    May 6, 2025

Follow Me

Follow Me
  • Cookie Policy
  • CORRECTIONS POLICY
  • PRIVACY POLICY
  • TERMS OF SERVICE

Hosted by Byohosting – Most Recommended Web Hosting – for complains, abuse, advertising contact: o f f i c e @byohosting.com


Back To Top
Newsy Today
  • Business
  • Entertainment
  • Health
  • News
  • Sport
  • Tech
  • World